BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 45 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $5,211,000 | -10.2% | 98,647 | +4.1% | 0.00% | 0.0% |
| Q2 2020 | $5,806,000 | +9.0% | 94,760 | +0.7% | 0.00% | 0.0% |
| Q1 2020 | $5,325,000 | -49.1% | 94,143 | -48.8% | 0.00% | 0.0% |
| Q4 2019 | $10,468,000 | +104.1% | 183,852 | +91.8% | 0.00% | 0.0% |
| Q3 2019 | $5,128,000 | -13.3% | 95,840 | -3.2% | 0.00% | 0.0% |
| Q2 2019 | $5,914,000 | +15.6% | 99,052 | +20.6% | 0.00% | 0.0% |
| Q1 2019 | $5,117,000 | -37.9% | 82,106 | -39.6% | 0.00% | 0.0% |
| Q4 2018 | $8,242,000 | +120.3% | 136,034 | +112.7% | 0.00% | 0.0% |
| Q3 2018 | $3,741,000 | +29.2% | 63,961 | -0.9% | 0.00% | 0.0% |
| Q2 2018 | $2,895,000 | +11.1% | 64,550 | +9.8% | 0.00% | 0.0% |
| Q1 2018 | $2,606,000 | +2.0% | 58,791 | -0.3% | 0.00% | 0.0% |
| Q4 2017 | $2,554,000 | +2.1% | 58,963 | +9.6% | 0.00% | 0.0% |
| Q3 2017 | $2,502,000 | -11.8% | 53,803 | -6.1% | 0.00% | 0.0% |
| Q2 2017 | $2,836,000 | -21.6% | 57,303 | -13.3% | 0.00% | 0.0% |
| Q1 2017 | $3,619,000 | +14.8% | 66,059 | +16.7% | 0.00% | 0.0% |
| Q4 2016 | $3,152,000 | +42.0% | 56,597 | +16.4% | 0.00% | 0.0% |
| Q3 2016 | $2,220,000 | +34.0% | 48,630 | +17.2% | 0.00% | 0.0% |
| Q2 2016 | $1,657,000 | +16.0% | 41,498 | +1.1% | 0.00% | 0.0% |
| Q1 2016 | $1,428,000 | -4.3% | 41,039 | +18.2% | 0.00% | 0.0% |
| Q4 2015 | $1,492,000 | -5.9% | 34,731 | -4.7% | 0.00% | 0.0% |
| Q3 2015 | $1,586,000 | -12.3% | 36,440 | +3.9% | 0.00% | 0.0% |
| Q2 2015 | $1,809,000 | +37.5% | 35,069 | +4.3% | 0.00% | 0.0% |
| Q1 2015 | $1,316,000 | +12.4% | 33,631 | +10.9% | 0.00% | 0.0% |
| Q4 2014 | $1,171,000 | +42.5% | 30,327 | +30.2% | 0.00% | 0.0% |
| Q3 2014 | $822,000 | +44.5% | 23,291 | +10.2% | 0.00% | – |
| Q2 2014 | $569,000 | +45.5% | 21,130 | +39.8% | 0.00% | – |
| Q1 2014 | $391,000 | +15.7% | 15,119 | -3.2% | 0.00% | – |
| Q4 2013 | $338,000 | +11.2% | 15,624 | +0.2% | 0.00% | – |
| Q3 2013 | $304,000 | +25.1% | 15,592 | -0.1% | 0.00% | – |
| Q2 2013 | $243,000 | – | 15,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 211,370 | $9,833,000 | 5.80% |
| JW Asset Management, LLC | 73,649 | $3,426,000 | 2.51% |
| NORTHPOINTE CAPITAL LLC | 135,657 | $6,311,000 | 0.67% |
| Elk Creek Partners, LLC | 170,102 | $7,913,000 | 0.50% |
| RICE HALL JAMES & ASSOCIATES, LLC | 156,167 | $7,265,000 | 0.32% |
| Ativo Capital Management LLC | 22,592 | $1,051,000 | 0.28% |
| Matarin Capital Management, LLC | 59,077 | $2,748,262,000 | 0.23% |
| ISTHMUS PARTNERS, LLC | 16,753 | $779,000 | 0.22% |
| CADENCE CAPITAL MANAGEMENT LLC | 29,586 | $1,376,000 | 0.09% |
| ALGERT GLOBAL LLC | 7,834 | $364,000 | 0.08% |